Arsenic trioxide Clinical Trials

4 actively recruiting trials across 1 location

Also known as: ATO, Arsenic (III) Oxide, Arsenic Sesquioxide, Arsenous Acid, Arsenous Acid Anhydride +3 more

Pipeline

Phase 2: 4

Top Sponsors

Yang Li1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
M.D. Anderson Cancer Center1
Associazione Italiana Ematologia Oncologia Pediatrica1

Indications

Cancer4
Acute Promyelocytic Leukemia With PML-RARA1
p53 Mutations1
Li-Fraumeni Syndrome1
Acute Promyelocytic Leukemia1

Other3 trials

Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer

Phase 2

Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

Phase 2

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Phase 2

Houston, Texas1 trial

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.